Cargando…
Clinical and economic impact of generic versus brand name meropenem use in an intensive care unit in Colombia
BACKGROUND: Recent studies suggest that sustained use of generic antibiotics may be associated with clinical failure and emergence of antibacterial resistance. The present study was designed to determine the clinical outcome between the use of generic meropenem (GM) and brand-name meropenem (BNM). A...
Autores principales: | Ordóñez, Karen, Feinstein, Max M., Reyes, Sergio, Hernández-Gómez, Cristhian, Pallares, Christian, Villegas, María V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427813/ https://www.ncbi.nlm.nih.gov/pubmed/31344357 http://dx.doi.org/10.1016/j.bjid.2019.06.010 |
Ejemplares similares
-
Effect of Generic vs. Brand-Name Meropenem on Mortality in a Colombian Hospital’s Intensive Care Unit
por: Feinstein, Max, et al.
Publicado: (2017) -
Antimicrobial Stewardship Challenges: Could Generic Antibiotic Use Policies Improve Economic Outcomes in Acute Care Hospitals?
por: Hernández-Gómez, Cristhian, et al.
Publicado: (2017) -
Comparison of Pharmaceutical Characteristics between Brand-Name Meropenem and Its Generics
por: Yang, Ping, et al.
Publicado: (2021) -
Brand Name Versus Generic?
por: Aungaroon, Gewalin
Publicado: (2023) -
The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs
por: Thakkar, Karan B., et al.
Publicado: (2013)